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Abstract
Background: A long-term existing schistosome infection can aid in maintaining immuno-homeostasis, thus providing 
protection against various types of autoimmune diseases to the infected host. Such benefits have often been 
associated with acute or egg stage infection and with the egg-induced Th2 response. However, since schistosome 
infection undergoes different stages, each associated with a specific induction of Th responses, the requirements for 
the ability of the different stages of schistosome infection to protect against autoimmune disease has not been 
elucidated. The present study was designed to study whether different stages of schistosome infection offer unique 
protection in collagen-induced arthritis and its mechanisms.
Results: Arthritis susceptible strain DBA/1 male mice were infected with Schistosoma japonicum for either 2 weeks 
resulting in early stage infection or for 7 weeks resulting in acute or egg stage infection. Following Schistosoma 
japonicum infection, collagen II was administered to induce collagen-induced arthritis, an animal model for human 
rheumatoid arthritis. Infection by Schistosoma japonicum significantly reduced the severity and the incidence of 
experimental autoimmune collagen-induced arthritis. However, this beneficial effect can only be provided by a pre-
established acute stage of infection but not by a pre-established early stage of the infection. The protection against 
collagen-induced arthritis correlated with reduced levels of anti-collagen II IgG, especially the subclass of IgG2a. 
Moreover, in protected mice increased levels of IL-4 were present at the time of collagen II injection together with 
sustained higher IL-4 levels during the course of arthritis development. In contrast, in unprotected mice minimal levels 
of IL-4 were present at the initial stage of collagen II challenge together with lack of IL-4 induction following 
Schistosoma japonicum infection.
Conclusion: The protective effect against collagen-induced arthritis provided by Schistosoma japonicum infection is 
infection stage-dependent. Furthermore, the ability of schistosomiasis to negatively regulate the onset of collagen-
induced arthritis is associated with a dominant as well as long-lasting Th2 response at the initiation and development 
of autoimmune joint and systemic inflammation.
Background
The increased incidences of autoimmune diseases and
atopic diseases found in developed countries [1,2] have
brought the 'hygiene hypothesis' into a hot area of study
and debate. The 'hygiene hypothesis' was first proposed
by the British scientist Dr. Strachan in 1989 after having
observed that having many siblings, especially older ones,
correlated with a decreased risk of hay fever [3]. This
finding has since been extended to a theory that the
changed pattern in or the reduced exposure to microor-
ganisms has led to a dysregulated immune system and
hence led to increases in certain disorders like atopy and
autoimmune diseases. Indeed, the mutual exclusion rela-
tionship between the incidence of immune-mediated dis-
orders with some kinds of microbes infections, especially
parasite infections, has repeatedly been reported in epi-
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demiological studies and in animal models[4,5]. However,
the requirement of the nature of parasite infection has
not been fully elucidated.
Worm-like metazoan organisms so called 'helminth',
including both nematoda (round worms) and platyhelm-
inthes (flatworms), have been recognized as important
infectious agents that can elicit beneficial effects to the
infected host in terms of conferring resistance to atopy or
autoimmune diseases. As a representative genus in para-
sitic platyhelminthes, schistosome or exposure to schisto-
some derived antigens have been found to offer
protection to a range of autoimmune disorders in experi-
mental animal models including type 1 diabetes in non-
obese diabetic (NOD) mice [6,7], experimental allergic
encephalomyelitis (EAE) (an animal model of multiple
sclerosis) [8,9], Graves' disease [10], inflammatory bowel
disease [11] and asthma [12]. However, the effect of helm-
inth infection on collagen-induced arthritis, an animal
model for human rheumatoid arthritis (RA), is less-well
studied[13,14].
The immune response elicited by Schistosoma mansoni
(Sm), the species that is mostly seen in Africa and South
America, progresses through two phases. During the first
2-5 weeks, called early stage infection, in which the host
is exposed to migrating immature parasites, the domi-
nant response is Th1. As the parasites mature, mate and
begin to produce eggs, the infection enters the acute stage
during which the Th1 response decreases and the Th2
response emerges and increases. The Th2 response
decreases after 12 weeks of chronic stage of the infection
[15,16]. Similar immune response profiles are also found
in Schistosoma Japonicum (Sj), the species mostly present
in Asia [17,18].
Majority of animal studies have found that the protec-
tive effects against immune-mediated disorders provided
by schistosome infection appeared to be associated with
Th2 immune response induced at egg-stage or acute
stage of infection. Only one study done by Osade et al on
collagen-induced arthritis (CIA) model has demonstrated
that the early stage of schistosome infection might exert
any beneficial effects [14]. They found that protective
effects against CIA in mice can be provided by 2 weeks
Sm infection [14], an early stage of Sm infection in which
eggs have not been produced in large quantities and a
Th2-dominant response is usually not seen [19]. This
observed protection against CIA offered at early-stage
infection lacking association with a Th2 response
prompted us to question whether different stages of
schistosome infection would offer unique protection and
whether a Th2-dominanted cytokine milieu provided by
egg-stage of schistosome infection was required to
achieve protective effects in CIA model. Answers to these
questions will help us to better understand the mecha-
nisms involved in parasite immune defense and use them
to prevent and treat autoimmune arthritis.
In this study, we selected either a 2 or 7 weeks Sj infec-
tion as early or acute stages of infection to study whether
different stages of Sj infection would affect the develop-
ment of CIA differently. We found that only the 7 weeks
infection regimen can offer protective or prophylactic
effects against CIA, whereas the 2 weeks infection failed
to provide any beneficial effect and even exacerbated the
disease. Further studies indicated that the protective
effects were correlated with decreased levels of anti-colla-
gen II IgG especially the IgG2a subclass. Cytokine pattern
analysis indicated that the presence of the Th2 cytokine
milieu at the initiation period of CIA together with its
sustained high levels was critical for the acquirement of
protective effects.
Results
The protective effects against arthritis were only observed 
when a pre-established Sj infection entered acute stage; 
whereas an early stage of Sj infection exacerbated the 
arthritis
Sm  infection can alleviate the development of several
autoimmune diseases like type I diabetes [6,7] and exper-
imental autoimmune encephalomyelitis [8,9] when the
infection enters the acute stage or egg-stage of infection
and when a Th2 response is dominant. To determine
whether different stages of schistosomiasis would affect
uniquely autoimmune arthritis in CIA model, the most
widely accepted animal model for human rheumatoid
arthritis (RA), and the role played by a pre-established
dominant Th2 environment, DBA/1 mice were infected
with the parasitic worm Sj  either for 2 weeks for pre-
established early stage of Sj infection (ESCIA, low Th2
response) or for 7 weeks for a pre-established acute stage
of Sj infection (ASCIA, Th2 dominant) before the induc-
tion of CIA by collagen II (CII) immunization.
As shown in Fig. 1, a significantly induced Th2
response as evaluated by a significant increase in IL-4
production by polyclonally activated spleen T cells was
found in the 7 weeks infection state as compared to the 2
weeks infection state and to mice not infected. However,
a slightly reduced Th1 cytokine IFN-γ production was
observed in mice infected with 7 weeks compared to
those infected with 2 weeks and those with no infection
but without any statistical significance. Thus, consistent
with the profiles found in other strains of mice infected
by Sm or by Sj [16-18], DBA/1 mice also displayed Th2
dominant response when the infection enters 7 weeks but
not the 2 weeks.
Arthritis was induced by application of collagen in
c o m p l e t e  F r e u n d ' s  a d j u v a n t  ( C F A )  f o l l o w e d  b y  i n c o m -
plete Freund's adjuvant (IFA) 21 days after first CII injec-
tion. Similar as reported [20], DBA/1 mice developedHe et al. BMC Immunology 2010, 11:28
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signs of arthritis around day 35 after CII immunization
(Fig 2). Injection of CII in ASCIA mice which were ani-
mals infected with the 7 weeks pre-established Sj infec-
tion before CIA induction, disease severity was
substantially reduced as assessed by ankle swelling (Fig
2E) and cumulative clinical arthritis scores of all four
limbs (Fig 2A). While control CIA animals reached a
cumulative arthritis score of 9 at day 56 with incidence
reaching about 85%, none of the ASCIA animals devel-
oped disease (Fig 2B). In contrast, injection of CII in
ESCIA mice which were animals infected with the 2
weeks pre-established Sj infection before CIA induction
failed to provide any prophylaxis on CIA whether arthri-
tis score (Fig 2C), arthritis incidence (Fig 2D) or clinical
signs (Fig 2E) were examined. In fact, the severity of
arthritis was even increased in ESCIA mice measured at
day 42 (Fig 2C). As a control, non collagen-immunized
mice did not develop arthritis regardless they were
infected with Sj or not (data not shown).
Anti-CII IgG and IgG2a levels were reduced in protected 
mice
Anti-CII IgG has been well known for its important role
in the pathogenesis of CIA and has become the marker
antibody for CIA [21]. We compared the anti-CII IgG lev-
els in protected ASCIA mice, unprotected ESCIA mice
and uninfected CIA mice. As shown in Fig 3A and 3B,
significantly decreased levels of anti-CII IgG were present
in protected ASCIA mice as compared to uninfected CIA
mice; whereas no significant difference was observed
between unprotected ESCIA mice and uninfected CIA
mice. This corresponded well with the prophylaxis effects
observed only in ASCIA mice but not in ESCIA mice.
When profiles of splenic B cells from different groups
were examined, B cell percentage was found to be
r e d u c e d  i n  A S C I A  m i c e  c o m p a r e d  t o  m i c e  o n l y  c h a l -
lenged with CIA (36.7% vs 47.8%). However this reduc-
tion does not seem to explain the significantly decreased
levels of anti-CII IgG found in ASCIA mice, because the
total B cell number was not decreased due to the spleno-
megaly found in ASCIA mice. Furthermore, a more
reduced percentage of B cells was found in ESCIA mice
compared to mice only challenged with CIA (27.7% vs
47.8%), though anti-CII IgG levels remained unaffected in
this group.
We further compared the levels of IgG1 or IgG2a sub-
classes in ASCIA mice without arthritis with those from
arthritic CIA or arthritic ESCIA mice. The level of IgG2a
was significantly reduced in ASCIA mice comparing to
CIA or ESCIA mice (Fig 3D), corresponding to lack of
arthritis. In contrast, IgG1 was reduced in ESCIA mice
comparing to CIA (Fig 3C), although both groups devel-
oped arthritis comparably (Fig 2). These data suggested
that IgG2a was more relevant to the pathogenesis of the
arthritis, and its reduction was associated with lack of
arthritis as found in ASCIA mice.
Protective effects in ASCIA mice were associated with 
enhanced production of IL-4 and IL-10 and reduced 
production of IFN-γ
Many studies have indicated the importance of different
Th subsets and the balance among them in the pathogen-
esis of arthritis in the CIA model [22]. To understand
whether the alleviation of arthritis in ASCIA mice was
associated with altered Th responses, splenocytes were
isolated at 8 weeks after CII immunization and stimu-
lated in vitro with anti-CD3 and anti-CD28 antibodies.
The production of IFN-γ was reduced and the production
Figure 1 IL-4 production is elevated in 7 to 10 weeks Sj infected DBA/1 mice. Splenocytes from DBA/1 mice infected with Sj either for 2 weeks 
or 7 to 10 weeks or not infected (CTRL) were stimulated by anti-CD3 and anti-CD28 antibodies for 72 hours in vitro. The supernatants were analyzed 
for IL-4 (A) and IFN-g (B). Shown are the combined results from two separate experiments. Significance was tested by one-way ANOVA with Bonferroni 
multiple comparison test with *** and ** as p < 0.001 and p < 0.01.He et al. BMC Immunology 2010, 11:28
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Figure 2 The protective effects against arthritis were only observed when a pre-established Sj infection entered acute stage. DBA/1 mice 
were infected with Sj for 2 weeks or 7 weeks prior to immunization with collagen II (CII) in CFA and named as ESCIA mice and ASCIA mice respectively. 
7 weeks Sj infection significantly reduced the severity (A), incidence (B) and clinical signs (E) of arthritis in ASCIA mice; whereas 2 weeks infection by Sj 
failed to decrease the severity (C), incidence (D) and clinical signs (E) of arthritis in ESCIA mice. Arthritis was scored weekly as described in Materials 
and Methods. Circle and square represented uninfected CIA mice and Sj infected CIA mice respectively. CIA data represented the combined results 
from two different age groups from multiple experiments due to their similar severity and incidence. Data in ESCIA mice were the means and the 
standard errors of the mean (SEM) of clinical scores from 20 individual mice combined from two separate experiments, while data in ASCIA mice were 
from 13 individual mice combined from three separate experiments. Significance was tested by two way ANOVA with Bonferroni multiple comparison 
test with *** as p < 0.001. Incidence was calculated on the ratio of the number of animals with arthritis score >= 3 on one joint over total number of 
mice.He et al. BMC Immunology 2010, 11:28
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of IL-4 was enhanced in ASCIA mice compared to ESCIA
and CIA mice (Fig 4A and 4B). Furthermore, moderately
enhanced IL-10 levels were also found in ASCIA mice
(Fig 4C). IL-17 production as induced by polyclonal stim-
ulation of T cells demonstrated no significant differences
between any of the groups (Fig 4D). Thus, an enhanced
Th2 response and a reduced Th1 response appeared to
correlate with the absence of disease.
The lack of significant IL-4 production in ESCIA mice
(Fig 4A) led us to question whether the strong Th1-
inducing agent complete Freund's adjuvant (CFA) [23]
used in CIA model would alter the induction of Th2
responses induced by schistosome infection. As shown in
Fig 5, the IL-4 production was low at 2 weeks of Sj infec-
tion, elevated at 7 to 10 weeks of infection and then
decreased after 15 weeks of infection. Thus the time
course of IL-4 production by Sj infection in DBA/1 mice
is consistent with the time course found in other strains
of mice infected by Sm or Sj [16,18]. However, the ele-
vated IL-4 production occurred during 7 to 10 weeks of Sj
infection was abrogated if CFA together with collagen
was administered at 2 weeks of Sj infection at which IL-4
production was still low. Interestingly, CFA and collagen
given at 7 weeks of infection at which IL-4 production
was high prohibited the IL-4 production from being
decreased when infection entered 15 week period. No
differences were observed in spleen size or the appear-
ance of the liver whether CFA was administered or not
(data not shown). These results indicated that high
amount of Th1-inducing agent CFA used in CIA model
per se did not reverse an established Th2 response in vivo
as seen in ASCIA mice which was in line with the obser-
Figure 3 Anti-CII IgG and IgG2a levels were reduced in protected mice. Serums were taken from 56 days after CII challenge from ESCIA mice, 
ASCIA mice and CIA mice. The levels of anti-CII IgG was measured in serially diluted serum and the levels of subclasses of anti-CII IgG1 or IgG2a were 
measured from 1:400 diluted serum by ELISA. (A) anti-CII IgG in ASCIA vs CIA (B) anti-CII IgG in ESCIA vs CIA (C) anti-CII IgG1 (D) anti-CII IgG2a. Results 
were obtained from 10 to 15 serum samples collected from two or three independently performed experiments. Data presented were the mean OD 
± SEM. Asterisks*** and ** represented P < 0.001 and P < 0.01 respectively by two way ANOVA for IgG or by one-way ANOVA for subclasses with Bon-
ferroni multiple comparison test.He et al. BMC Immunology 2010, 11:28
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vations made in vitro that an established Th2 response
was irreversible [24]. Furthermore, the ability of CFA to
prevent an ongoing Th2 response from being firmly
established as seen in ESCIA mice which may reflect the
fact that an early phase of the Th2 response is reversible
[24]. More intriguingly and significantly, presence of CFA
prolonged Th2 response which otherwise would be
greatly reduced seen in 15 weeks infected animals. Taken
together, these results indicated that a Th2 -biased milieu
present at the time when CII antigen was introduced as
well as during the development of arthritis correlated
with lack of arthritis in protected ASCIA animals.
FoxP3+ regulatory T cells were not different between 
protected and unprotected mice
It is widely accepted that FoxP3+ regulatory T cells(Treg)
play critical roles in pathogenesis of various of kinds of
autoimmune diseases including human RA[25,26]. Both
CD4+CD25+ T cells and CD4+CD25+FoxP3+ T cells in the
spleen were measured and compared. The correspon-
dence of these two populations of T cells was about 80-
90% (Table 1). There was a slightly increased representa-
tion of FoxP3+ Treg during infection, whether it was CIA
mice alone or Sj infection with CIA mice. However there
was no remarkable increase in FoxP3+ Treg in ASCIA
mice without arthritis compared to CIA or ESCIA mice
with arthritis.
Discussion
Helminth parasites inhabit immune-competent hosts for
long periods of time and appear to develop strategies to
induce strong anti-inflammatory responses in the
infected host. Loss of natural helminth exposure as a
result of improved hygiene and wide-use of anti-helminth
Figure 4 Protective effects in ASCIA mice were associated with enhanced production of IL-4 and IL-10 and reduced production of IFN-γ. 56 
days after CII immunization in ESCIA mice, ASCIA mice and CIA mice, splenocytes were stimulated by anti-CD3 and anti-CD28 antibodies for 72 hrs. 
The cytokine contents for IL-4 (A), IFN-g (B), IL-10 (C) and IL-17 (D) were measured by ELISA as described in the Materials and Methods. Shown are 
samples from individual mouse combined from two or three separately performed experiments. Asterisks* and ** represented P < 0.05 and P < 0.01 
respectively by one-way ANOVA with Bonferroni multiple comparison test.He et al. BMC Immunology 2010, 11:28
http://www.biomedcentral.com/1471-2172/11/28
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drugs result increased incidences of immune-mediated
disorders evidenced by epidemiological studies. On the
other hand, the helminths provide the host with more
balanced immuno-homeostasis and demonstrate benefi-
cial effects against various kinds of autoimmune diseases
in animal studies[4]. In fact several clinical trials have
attempted to use helminth to treat autoimmune disease
in patients and showed that exposure to helminths can
reduce disease activity in patients with immune-medi-
a t e d  d i s e a s e  l i k e  u l c e r a t i v e  c o l i t i s [ 5 ] .  I n  t h i s  s t u d y ,  w e
investigated the beneficial effect of schistosome infection
on less-well studied collagen-induced arthritis mouse
model. The beneficial effect is found to be associated
with reduced anti-collagen II IgG production and with a
Th2 cytokine environment induced at egg-stage of infec-
tion.
The anti-CII antibodies have been recognized as
important pathogenic factors in the initiation and devel-
opment of CIA in mice. It has been reported that arthritis
can be transferred passively to naive animals with CII-
reactive serum [27], and by monoclonal antibody to CII
[28]. In fact, a different mouse model collagen antibody-
induced arthritis (CAIA) for human RA is established by
passively transferring arthritogenic antibodies against
collagen. Further studies using the CAIA model found
that the subclass of IgG2a appears to be more efficient in
inducing RA probably due to its strong capacity to acti-
vate complement through the classical pathway [29]. The
ability of inhibiting arthritis by egg-stage Sj infection in
ASCIA mice but not by early stage infection found in our
study was well correlated with reduced levels of anti-CII
IgG, especially the levels of IgG2a. This alteration in class
switch may reflect the significantly repressed IgG2a-pro-
moting cytokine IFN-γ production found in ASCIA
group. On the other hand, the positive association
between elevated IgG2a and the occurrence of arthritis
indicates the pathogenic role played by Th1 cells and the
beneficial role played by Th2 cells. Consequently, benefi-
cial effects against CIA can only be found in the acute or
egg-stage of Sj infection but not in early stage infection
before eggs are produced in large quantity.
Schistosomiasis is a well-characterized Th2 response-
dominated disease [16]. Shortly after the beginning of egg
deposition, a strong egg-specific Th2 response develops
characterized by high levels of IL-4, IL-5, and IL-13
which decreases when the infection enters the chronic
stage [17,30]. Not surprisingly the negative effect of schis-
tosome infection on the induction and development of
type I diabetes in NOD model [6], multiple sclerosis in
EAE model [8] and in mouse model of Graves' hyperthy-
roidism [10] has repeatedly been reported in mice
infected by schistosme for 6-8 weeks before autoimmune
diseases were induced. By comparison between the bene-
ficial effects of Sj infection and the IL-4 production pro-
files, our study clearly demonstrated that the presence of
Figure 5 The effects of CFA on the IL-4 production induced by Sj 
infection. Splenocytes from mice of uninfected (CTRL), 2 weeks of Sj 
infection, 7 to 10 weeks of Sj infection, 15 weeks of Sj infection, CIA, ES-
CIA (total 10 weeks of Sj infection), ASCIA (total 15 weeks of Sj infection) 
were stimulated by anti-CD3 and anti-CD28 antibodies for 72 hrs. The 
IL-4 contents in the supernatants were measured by ELISA. Shown are 
samples from individual mouse combined from two or three separate-
ly performed experiments. Asterisks* and ** represented P < 0.05 and 
P < 0.01 respectively by one-way ANOVA with Bonferroni multiple 
comparison test.
Table 1: CD4+CD25+FoxP3+ regulatory T Cell compartment in the spleen
Mouse Group %CD4(SD)
CD4+CD25+ CD4+CD25+FoxP3+
Normal 8.9(0.3) 7.4(0.9)
CIA 10.9(2.0) 9.3(3.1)
ESCIA 10.9(1.6) 7.7(0.8)
ASCIA 12.9(2.2) 10.5(1.9)
The number of mice per group is from 8 to 13 from two or three separately performed experiments. Each value was derived from the means 
of individual mouse in the group.He et al. BMC Immunology 2010, 11:28
http://www.biomedcentral.com/1471-2172/11/28
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Th2 at the beginning stage of autoimmune attack was
important in conferring the protection. In addition, our
study also demonstrated a positive correlation between
the prolonged presence of elevated Th2 levels during the
development stage of autoinflammatory response and the
absence of disease.
We noticed the different result obtained by Osada et al
[14] in which 2 weeks prior Schistosome infection was
shown to offer protection in CIA. An obvious difference
between our study and that of Osada's was that different
strains of Schistosoma were used, ie, Sm in their study
and Sj in ours. Since the amount of eggs along with the
levels of Th2 response induced are low after 2 weeks Sm
infection [19], Osada's study seems to suggest that the
Th2 milieu present at initiation phase of autoimmune
attack is not crucial to achieve the protection. In addition,
elevated IL-4 production was still found to be produced
by activated splenocytes from infected and CFA injected
mice, suggesting that the injection of the Th1-promoting
agent CFA in their study has little impact on the develop-
ment of the Th2 response. It is not clear at present that if
different strains of worms used can fully explain the dif-
ferent results obtained.
Another possible protective mechanism involved in our
study was likely associated with the enhanced production
of regulatory cytokine IL-10 by activated T cells found in
protected animals. Th2 cells, FoxP3+ CD4+ Treg cells and
FoxP3- IL-10-producing CD4+ so called Tr1 cells[31] may
all contribute to this induced production of T cell-derived
IL-10. Although no significant increase in Treg numbers
was found in protected group, the possibility that the
activities of Treg and Tr1 cells were enhanced can not be
excluded. No significant difference on production of IL-
17 was found among protected mice, unprotected mice
and CIA mice, even though Th17 appears to be accepted
as the more critical pathogenic Th cells in the CIA model
than Th1 [32].
Our study also provided an approach to explore the
plasticity of Th subsets in vivo. In vitro studies have dem-
onstrated that Th17 is an unstable subset [33], whereas
Th1 and Th2 subsets, once they are well established, are
not reversible [24]. With the application of Th1-promot-
ing agent CFA at different time point, we found that CFA
together with collagen is able to inhibit the Th2 response
only at 2 weeks but not at 7 weeks of Sj infection when
Th2 development is at an early stage but not well-estab-
lished. Thus our results for the first time in vivo indicated
that a well established Th2 response can not be reversed,
whereas an early stage Th2 response can be reversed in
the presence of CFA treatment. This phenomenon may
serve as the basis for the beneficial effects by Sj infection
in maintaining immune-homeostasis in infected host
hence providing protection against immune-mediated
diseases.
Conclusion
In summary, we demonstrated in this study that Schisto-
soma japonicum infection like Schistosoma masoni can
inhibit the incidence and severity of autoimmune arthri-
tis in the mouse CIA model. However this effect is abso-
lutely infection stage-dependent, ie, it occurs at acute
stage of infection but not at early stage of infection. Fur-
thermore this beneficial effect is positively associated
with the presence of an irreversibly established Th2
response at the initiation of autoimmune response and
with its sustained high levels during the development of
arthritis. Thus our study provides more insight into the
complex mechanisms regarding to the "hygiene hypothe-
sis" and the potential difficulties faced when egg or egg-
derived materials are used for therapeutic agents in Th1-
associated autoimmune diseases.
Methods
Mice
6-12 weeks old male DBA/1 mice were purchased from
Songjiang Animal Facility of the Chinese Academy of Sci-
ences of Shanghai. All mice were maintained under spe-
cific pathogen-free conditions and fed with standard
laboratory food and water. All procedures performed on
animals within this study were conducted in accordance
with and by approval of the Internal Review Board of
Tongji University School of Medicine.
Schistosoma japonicum Infection in mice
DBA/1 mice were infected by percutaneous exposure of
the abdomen with 20 cercariae per mouse. Cercariae of Sj
used for all experiments were obtained from Oncomela-
nia hupensis snails collected from Guichi County, Anhui
Province, and maintained at the National Institute of Par-
asitic Diseases, Shanghai. Uninfected animals of the same
sex and age were maintained as controls. At the end of
each experiment, the livers and spleens from infected
mice were routinely examined to ensure that schistoso-
miasis was established.
Induction and assessment of CIA
CIA was induced according to the methods as described
by Current Protocol in Immunology [34]. Chicken type II
collagen(CII) (Sigma) was dissolved in 0.05 M acetic acid
at concentration of 2 mg/ml by stirring overnight at 4°C
and was then emulsified in an equal volume of complete
Freund's adjuvant (CFA) containing 4 mg/ml Mycobacte-
rium tuberculosis (Chondrex, Redmond, WA). Male
DBA/1 mice were injected intradermally at the base of
the tail with 0.1 ml of emulsion containing 100 μg of col-
lagen II. 21 days after primary immunization, mice were
boosted with 0.1 ml of the mixture of 1 mg/ml CII emul-
s i f i e d  i n  i n c o m p l e t e  F r e u n d ' s  a d j u v a n t  ( S i g m a )  v i a  t h e
same route. In order to keep the age of animals compara-He et al. BMC Immunology 2010, 11:28
http://www.biomedcentral.com/1471-2172/11/28
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ble for arthritis profiles, different ages of mice were
selected for experiments for either early or acute infec-
tion. For experiments of early stage of infection, mice of
10-12 weeks old were used with first injection of CII at 2
weeks after Sj infection, named ESCIA mice. For experi-
ment of acute stage of infection, mice of 6-8 weeks old
were used with first injection of CII at 7 weeks after Sj
infection, named ASCIA mice.
Arthritis was scored as described in Current Protocol
in Immunology [34] from day 21 using a scale of 0-4 per
limb in which 0 = No evidence of redness and swelling; 1
= Redness and mild swelling confined to the mid-foot or
ankle joint; 2 = Redness and mild swelling extending from
the ankle to the mid-foot; 3 = Redness and moderate
swelling extending from the ankle to the metatarsal
joints; 4 = Redness and severe swelling encompass the
ankle, foot and digits. The total arthritis score in one
mouse is the sum of scores of all four feet with maximum
score of 16. The incidence of CIA was calculated based
on the number of mice with at least one foot scored
higher than 3.
Measurement of antibodies against CII
The levels of anti-CII IgG or its subclasses in serum were
measured by ELISA. Serum was collected at day 56 after
first CII immunization. In brief, 96-well ELISA
microplates (Greiner) were coated with CII at 5 μg/ml
dissolved in 0.1 N NaHCO3, pH9.6 buffer at 100 μl/well
at 4°C overnight. 100 μl of diluted serum sample was
incubated at 4°C overnight. The plates were washed with
PBST (0.5% Tween-20 in PBS) three times, followed by
a d d i n g  p e r o x i d a s e  c o n j u g a t e d  g o a t  a n t i - m o u s e  I g G  a t
1:2000 (CapitalBo Corp., Beijing) or peroxidase-conju-
gated anti-mouse IgG1 or anti-mouse IgG2a at 1:10000
(Santa Cruz) at 100 μl/well. After 2 hr incubation at room
temperature and wash, the final color development was
achieved by adding peroxidase substrate ABTS (2,2'-
Azino-bis(3-Ethylbenzthiazoline-6-Sulfonic Acid) ,
Sigma) to each well at 100 μl/well and the absorbance was
measured at 405 nm at appropriate time.
Measurement of cytokine production by splenocytes
To study cytokine expression by T lymphocytes, isolated
spleen cells (5 × 106  cells/well) from mice that were
immunized by CII for 8 weeks or from control mice were
stimulated with 1 μg/ml anti-CD3ε (eBioscience) and 1
μg/ml anti-CD28 (eBioscience) at 37°C, 5%CO2 in 10%
FCS/RPMI(GIBCO) culture medium for 72 hrs. The
cytokine contents in the supernatants were analyzed by
ELISA analysis as described by the e-Bioscience protocol
http://www.ebioscience.com. All coating and detection
antibodies were purchased from e-Bioscience (Dakewe,
Shanghai), and recombinant mouse cytokines were
obtained from Peprotech (Dakewe, Shanghai) for stan-
dard curves in ELISA assay.
Flow cytometric analysis of regulatory T cell, T cell and B 
cell
The levels of regulatory T cell (Treg) in splenocytes were
measured by flowcytometry analysis as instructed by the
Mouse Regulatory T cell Staining Kit (eBioscience). T cell
and B cell were detected by FACS analysis staining with
either FITC-anti-CD3ε (eBioscience) or PE-anti-B220
(eBioscience). All data were collected on a FACSCalibur
(Becton Dickinson) and analyzed with FlowJo software
(Tree Star, Ashland, OR).
Statistical analyses
Differences in arthritis score and differences in antibody
levels of anti-CII IgG were analyzed with two-way
ANOVA with Bonferroni multiple comparison tests. Dif-
ferences in levels of cytokine production and subclasses
of IgG were analyzed by one-way ANOVA with Bonfer-
roni multiple comparison test. Calculations for statistical
analysis were performed with Prism software. P < 0.05(*),
P < 0.01(**) and P < 0.001(***) were considered as statisti-
cally significant.
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